{"database": "lobbying", "table": "lobbying_activities", "rows": [[2505838, "51c0e28d-a0b3-488d-8734-ad3038be4717", "Q3", "GREATER NEW YORK HOSPITAL ASSOCIATION", 16830, "GREATER NEW YORK HOSPITAL ASSOCIATION", 2020, "third_quarter", "MMM", "Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. \nSupport increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). \nAdvocate for changes to indirect medical education payments to account for COVID-19 response efforts. \nDiscuss issues related to Medicare accelerated payments with White House, HHS, CMS and Congressional staff.\nAdvocate for continued Federal funding for New York States DSRIP program. \nDiscuss Medicare and Medicaid issues with the CMS Administrator.\nDiscuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. \nDiscuss GNYHA's legislative priorities with Congressional staff: a delay of cuts Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), and the Affordable Care Act (support).\nOppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. \nEducate Congressional staff and lawmakers on Medicare for All. \nSupport graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439).\nDiscuss technical assistance regarding the Opioid Workforce Act (H.R. 3414/S. 2439) with committee staff.\nDiscuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff.\nDiscuss New York State's Partnership for Patients initiative with CMS contract officers.\nDiscuss GME rural training tracks and possible reforms with Congressional staff.\nDiscuss the ET3 model with staff from CMMI.\nDiscuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. \nSpoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues\nDiscuss issues concerning DSH hospitals with the Executive Branch.\nDiscuss Medicare and Medicaid issues with the CMS Administrator.\nDiscuss Lower Drug Costs Now Act (H.R.3) with Congressional staff.\nDiscuss issues related to telehealth and HIT with staff from CMS, the White House and Congressional staff.\nDiscuss the HEROES Act (H.R. 6800) and other COVID-19 phase four response legislation with lawmakers, Congressional staff, HHS and the White House. \nDiscuss disbursements from the Public Health and Social Services Emergency Fund with HHS, the White House, and Congressional staff and lawmakers. \nDiscuss Medicare Advance Payment forgiveness with HHS and Congressional staff, advocated for H.R. 7292 (support).\nDiscuss a range of other COVID-19 priorities with Congressional staff including ensuring Medicare advantage plans comply with increased COVID-19 Medicare payments (support), an add-on payment for COVID-19 care (support), and crisis pay for health care workers (support).\nSupport a delay of Medicaid DSH reimbursement cuts in COVID-19 response package and a delay or repeal of the Medicaid Fiscal Accountability Regulation.\nDiscuss increased Federal Medical Assistance Percentages (support) and increased funding for state and local governments (support) with Congressional staff. \nDiscuss Medicare Rule on Physician Time Studies (42 CFR 415.60) with CMS. \nDiscuss disclosure of patient information to the media with HHS.\nDiscuss Medicare Rules regarding new teaching hospitals with CMS.\nDiscuss alternate care site billing with CMS.", "Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Defense, Dept of (DOD),Executive Office of the President (EOP),Federal Bureau of Investigation (FBI),Federal Emergency Management Agency (FEMA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),President of the U.S.,SENATE,Small Business Administration (SBA),Substance Abuse & Mental Health Services Administration (SAMHSA),White House Office", null, 550000, 0, 0, "2020-10-09T15:54:34.877000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2505838"], "units": {}, "query_ms": 0.6749880267307162, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}